Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Preparation of Calibration Curve in UV – V 2.0

Posted on By

Analytical Method Development: Preparation of Calibration Curve in UV – V 2.0

SOP for Preparation of Calibration Curve in UV Spectrophotometric Analysis


Department Analytical Method Development
SOP No. SOP/AMD/095/2025
Supersedes SOP/AMD/095/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines a systematic approach to prepare and evaluate calibration curves using UV-visible spectrophotometry for analytical method development. The curve establishes the linear relationship between analyte concentration and

absorbance, essential for quantitative analysis of Active Pharmaceutical Ingredients (APIs).

2. Scope

This SOP applies to the Analytical Method Development (AMD) department and is relevant for all methods requiring quantification of APIs or finished formulations through UV spectrophotometric techniques using a standard calibration curve.

3. Responsibilities

  • Analytical Chemist: Prepares standard dilutions, measures absorbance, and generates the calibration curve.
  • Reviewer: Verifies dilution accuracy, regression analysis, and correlation coefficient.
  • QA Officer: Reviews calibration data, curve accuracy, and documentation integrity.
  • Head – AMD: Approves the final calibration curve and data for method validation and routine analysis.
See also  Analytical Method Development: SOP for Development of Photostability Testing Methods - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that all calibration curves are scientifically valid, statistically evaluated, and compliant with ICH Q2(R1) and pharmacopeial requirements.

5. Procedure

5.1 Standard Stock Solution Preparation

  1. Weigh accurately about 100 mg of API (or reference standard).
  2. Dissolve in a suitable solvent and make up to 100 mL to achieve 1 mg/mL (1000 µg/mL) solution.
  3. Sonicate if required for complete dissolution.
  4. Label as “Standard Stock Solution” and record in Annexure-1: Standard Preparation Log.

5.2 Working Standard Dilutions

  1. Prepare a minimum of five standard dilutions in the range of 50% to 150% of the target concentration (e.g., 10, 15, 20, 25, 30 µg/mL).
  2. Use Class A volumetric flasks and pipettes for accurate volume transfer.
  3. Document dilution details in Annexure-2: Dilution Worksheet.

5.3 Measurement of Absorbance

  1. Turn on UV-visible spectrophotometer and allow warm-up for 30 minutes.
  2. Set wavelength to previously determined λmax (e.g., 274 nm).
  3. Use the solvent as blank and measure absorbance of each concentration in triplicate using 1 cm path length quartz cuvettes.
  4. Log readings in Annexure-3: Absorbance Record Sheet.
See also  Analytical Method Development: BET Method Development (Bacterial Endotoxins Test) - V 2.0

5.4 Plotting Calibration Curve

  1. Plot mean absorbance (Y-axis) against concentration (X-axis).
  2. Perform linear regression using Excel or validated software.
  3. Record slope, intercept, and correlation coefficient (r or R²).
  4. Sample output: y = 0.032x + 0.005; R² = 0.9998
  5. Include plot and equation in Annexure-4: Calibration Curve Summary.

5.5 Acceptance Criteria

  1. Correlation coefficient (R²): ≥ 0.995
  2. %RSD of absorbance: ≤ 2.0% at each level
  3. Linearity: Slope should be consistent across batches
  4. Intercept: Close to zero (acceptable if within ±0.010)
  5. If criteria are not met, repeat dilution preparation and measurement.

5.6 Use of Calibration Curve

  1. Use the equation y = mx + c to calculate unknown sample concentrations.
  2. Example: If absorbance = 0.678, and curve equation is y = 0.032x + 0.005
    x = (0.678 – 0.005) / 0.032 = 21 µg/mL
    
  3. Report final result after applying dilution factors.

6. Abbreviations

  • UV: Ultraviolet
  • API: Active Pharmaceutical Ingredient
  • RSD: Relative Standard Deviation
  • λmax: Wavelength of Maximum Absorbance
  • SOP: Standard Operating Procedure
  • R²: Coefficient of Determination

7. Documents

  1. Standard Preparation Log – Annexure-1
  2. Dilution Worksheet – Annexure-2
  3. Absorbance Record Sheet – Annexure-3
  4. Calibration Curve Summary – Annexure-4
See also  Analytical Method Development: SOP for Oxidative Degradation Pathway Profiling - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <857> – Ultraviolet-Visible Spectroscopy
  • FDA Guidance for Industry – Analytical Procedures and Methods Validation
  • Instrument Manufacturer Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Standard Preparation Log

Sample ID Weight (mg) Solvent Final Volume (mL) Prepared By
STD-095 100.0 Methanol 100 Sunita Reddy

Annexure-2: Dilution Worksheet

Level (%) Concentration (µg/mL) Dilution Final Volume (mL)
50% 10 1 mL stock + 9 mL diluent 10
150% 30 3 mL stock + 7 mL diluent 10

Annexure-3: Absorbance Record Sheet

Concentration (µg/mL) Replicate 1 Replicate 2 Replicate 3 Mean
10 0.325 0.326 0.324 0.325

Annexure-4: Calibration Curve Summary

Curve Equation R² Slope Intercept
y = 0.032x + 0.005 0.9998 0.032 0.005

Attach printed curve and Excel regression output here.

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added dilution calculation examples and R² criteria update Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: BA-BE Studies: SOP for Bioanalytical Sample Batch Preparation – V 2.0
Next Post: Gel Manufacturing: SOP for Cleaning pH Meters and Calibration Devices – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version